Chronic exposure to Δ9-tetrahydrocannabinol downregulates oxytocin and oxytocin-associated neurophysin in specific brain areas

Molecular and Cellular Neuroscience

Volumn 31, Issue 4, 2006, Pages 795-804

  Butovsky, Elena ^a   Juknat, Ana ^a   Elbaz, Judith ^a   Shabat Simon, Maytal ^a   Eilam, Raya ^a   Zangen, Abraham ^a   Altstein, Miriam ^b   Vogel, Zvi ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b VOLCANI CENTER   (Israel)

Author keywords

9 THC; Cannabinoids; Neurophysin; Nucleus accumbens; Oxytocin; Reward system; Ventral tegmental area

Indexed keywords

NEUROPHYSIN; OXYTOCIN; TETRAHYDROCANNABINOL; MESSENGER RNA; PSYCHEDELIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DOWN REGULATION; DRUG DEPENDENCE; DRUG EXPOSURE; DRUG TOLERANCE; DRUG WITHDRAWAL; GENE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REWARD; THALAMUS MIDLINE NUCLEUS; ANIMAL; DRUG EFFECT; GENETICS; HISTOLOGY; MALE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALIA;

ANIMALS; BRAIN; HALLUCINOGENS; MALE; NEUROPHYSINS; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TETRAHYDROCANNABINOL;

EID: 33645421778     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2006.01.008     Document Type: Article

References (79)

1. M. Altstein, M.H. Whitnall, S. House, S. Key, and H. Gainer An immunochemical analysis of oxytocin and vasopressin prohormone processing in vivo Peptides 9 1988 87 105
2. S. Ammon-Treiber, and V. Höllt Morphine-induced changes of gene expression in the brain Addict. Biol. 10 2005 81 89
3. G.J. Bassell, Y. Oleynikov, and R.H. Singer The travels of mRNAs through all cells large and small FASEB J. 13 1999 447 454
4. 9-Tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase J. Biol. Chem. 271 1966 9902 9905
5. Y. Ben-Barak, J.T. Russell, M.H. Whitnall, K. Ozato, and H. Gainer Neurophysin in the hypothalamo-neurohypophysial system. Production and characterization of monoclonal antibodies J. Neurosci. 5 1985 81 97
6. M.T. Berhow, N. Hiroi, and E.J. Nestler Regulation of ERK, part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine J. Neurosci. 16 1996 4707 4715
7. M.J. Brownstein, J.T. Russell, and H. Gainer Synthesis, transport, and release of posterior pituitary hormones Science 207 1980 373 378
8. J.P. Burbach, S.M. Luckman, D. Murphy, and H. Gainer Gene regulation in the magnocellular hypothalamo-neurohypophysial system Physiol. Rev. 81 2001 1197 1267
9. 9-tetrahydrocannabinol J. Neurochem. 93 2005 802 811
10. A.R. Caffe, P.C. Van Ryen, T.P. Van der Woude, and F.W. Van Leeuwen Vasopressin and oxytocin systems in the brain and upper spinal cord of Macaca fascicularis J. Comp. Neurol. 287 1989 302 325
11. C.S. Carter Developmental consequences of oxytocin Physiol. Behav. 79 2003 383 397
12. M. Castel, and J.F. Morris The neurophysin-containing innervation of the forebrain of the mouse Neuroscience 24 1988 937 966
13. J. Chao, and E.J. Nestler Molecular neurobiology of drug addiction Annu. Rev. Med. 55 2004 113 132
14. S.S. Cui, R.C. Bowen, G.B. Gu, D.K. Hannesson, P.H. Yu, and X. Zhang Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation J. Neurosci. 21 2001 9867 9876
15. J. Dogterom, F.G.M. Snijdewint, and R.M. Buijs The distribution of vasopressin and oxytocin in the rat brain Neurosci. Lett. 9 1978 341 346
16. J.C. Elliott, D.A. Lubin, C.H. Walker, and J.M. Johns Acute cocaine alters oxytocin levels in the medial preoptic area and amygdala in lactating rat dams: implications for cocaine-induced changes in maternal behavior and maternal aggression Neuropeptides 35 2001 127 134
17. 9- tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting drugs (cocaine and morphine) Mol. Brain Res. 71 1999 313 324
18. L. Fattore, C.G., C.M. Martellota, and W. Fratta Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN55,212-2 in rats Psychopharmacology 156 2001 410 416
19. H. Gainer, and S. Wray Cellular and molecular biology of oxytocin and vasopressin E. Knobil J.D. Neill The Physiology of Reproduction 1994 Raven Press, Ltd. New York 1099 1119
20. E.L. Gardner Addictive potential of cannabinoids: the underlying neurobiology Chem. Phys. Lipids 121 2002 267 290
21. E.L. Gardner, and S.R. Vorel Cannabinoid transmission and reward-related events Neurobiol. Dis. 5 1998 502 533
22. B. Gingrich, Y. Lui, C. Cascio, Z. Wang, and T.R. Insel Dopamine D2 receptors in the nucleus accumbens are important for social attachment in female prairie voles Behav. Neurosci. 114 2000 173 183
23. M. Hallbeck, D. Larhammar, and A. Blomqvist Neuropeptide expression in rat paraventricular hypothalamic neurons that project to the spinal cord J. Comp. Neurol. 433 2001 222 238
24. A.C. Howlett Pharmacology of cannabinoid receptors Annu. Rev. Pharmacol. Toxicol. 35 1995 607 634
25. A.C. Howlett Efficacy in CB1 receptor-mediated signal transduction. Review Br. J. Pharmacol. 142 2004 1209 1218
26. A. Humphies, and D.A. Carter Circadian dependency of nocturnal immediate-early protein induction in rat retina Biochem. Biophys. Res. Commun. 320 2004 551 556
27. T.R. Insel Is social attachment an addictive disorder? Physiol. Behav. 79 2003 351 357
28. T.R. Insel, and L.J. Young The neurobiology of attachment Nat. Rev., Neurosci. 2 2001 129 136
29. L. Iversen Cannabis and the brain Brain Res. 126 2003 1256 1270
30. 9-tetrahydrocannabinol Life Sci. 63 1998 381 384
31. G.F. Jirikowski, P.P. Sanna, and F.E. Bloom mRNA coding for oxytocin is present in axons of the hypothalamo-neurohypophysial tract Proc. Natl. Acad. Sci. U. S. A. 87 1990 7400 7404
32. 9-THC in rats Physiol. Genomics 3 2000 175 185
33. G.L. Kovacs, Z. Sarnyai, and G. Szabo Oxytocin and addiction: a review Psychoneuroendocrinology 23 1998 945 962
34. P. Kremarik, M.J. Freund-Mercier, and M.E. Stoeckel Histoautoradiographic detection of oxytocin- and vasopressin-binding sites in the telencephalon of the rat J. Comp. Neurol. 15 1993 343 359
35. S.B. Lane-Ladd, J. Pineda, V.A. Boundy, T. Pfeuffer, J. Krupinski, G.K. Aghajanian, and E.J. Nestler CREB in the locus coeruleus: biochemical, physiological and behavioural evidence for a role in opiate dependence J. Neurosci. 17 1997 7890 7901
36. A.H. Lichtman, and B.R. Martin Cannabinoid tolerance and dependence R. Pertwee Handbook of Experimental Pharmacology 2005 Springer-Verlag Heidelberg 691 717
37. K.C. Light, K.M. Grewen, J.A. Amico, M. Boccia, K.A. Brownley, and J.M. Johns Deficits in plasma oxytocin responses and increased negative affect, stress, and blood pressure in mothers with cocaine exposure during pregnancy Addict. Behav. 29 2004 1541 1564
38. M.M. Lim, A.Z. Murphy, and L.J. Young Ventral striatopallidal oxytocin and vasopressin V1a receptors in the monogamous prairie vole (Microtus ochrogaster) J. Comp. Neurol. 468 2004 555 570
39. Y. Liu, and Z.X. Wang Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles Neuroscience 121 2003 537 544
40. C.R. Lupica, A.C. Riegel, and A.F. Hoffman Marijuana and cannabinoid regulation of brain reward circuits Br. J. Pharmacol. 143 2004 227 234
41. R. Maldonado Study of cannabinoid dependence in animals Pharmacol. Ther. 95 2002 153 164
42. B.R. Martin, L.J. Sim-Selley, and D.E. Selley Signaling pathways involved in the development of cannabinoid tolerance Trends Pharmacol. Sci. 25 2004 325 330
43. J.R. Mathiasen, E.R. Larson, M.A. Ariano, and C.D. Sladek Neurophysin expression is stimulated by dopamine D1 agonist in dispersed hypothalamic cultures Am. J. Physiol. 270 1996 R404 R412
44. I. Matsuoka, M.R., N. Defer, F. Noel, J. Hanoune, and B.P. Roques Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA Eur. J. Pharmacol. 268 1994 215 221
45. N. Matus-Leibovitch, V. Ezra-Macabee, D. Saya, B. Attali, T. Avidor-Reiss, J. Barg, and Z. Vogel Increased expression of synapsin I mRNA in defined areas of the rat central nervous system following chronic morphine treatment Mol. Brain Res. 34 1995 221 230
46. + channels in rat spinal cord Mol. Brain Res. 40 1996 261 270
47. N. Matus-Leibovitch, I. Nevo, and Z. Vogel Differential distribution of synapsin IIa and IIb mRNAs in various brain structures and the effect of chronic morphine administration on the regional expression of these isoforms Brain Res. Mol. Brain Res. 45 1997 301 316
48. C.A. McClung, and E.J. Nestler Regulation of gene expression and cocaine reward by CREB and ΔFosB Nat. Neurosci. 6 2003 1208 1215
49. G.E. Meredith, S. Callen, and D.A. Scheuer Brain-derived neurotrophic factor expression is increased in the rat amygdale, piriform cortex and hypothalamus following repeated amphetamine administration Brain Res. 949 2002 218 227
50. E. Mohr, and D. Richter Diversity of mRNAs in the axonal compartment of peptidergic neurons in the rat Eur. J. Neurosci. 4 1992 870 876
51. E. Mohr, I. Kachele, C. Mullin, and D. Richter Rat vasopressin mRNA: a model system to characterize cis-acting elements and trans-acting factors involved in dendritic mRNA sorting Prog. Brain Res. 139 2002 211 224
52. S. Mukhopadhyay, J.-Y. Shim, A.-A. Assi, D. Norford, and A.C. Howlett CB1 cannabinoid receptor-G protein association: a possible mechanism for differential signaling Chem. Phys. Lipids 121 2002 91 109
53. E.J. Nestler Molecular neurobiology of addiction Am. J. Addict. 201 2001 201 217
54. E.J. Nestler Molecular basis of long-term plasticity underlying addiction Nat. Rev., Neurosci. 2 2001 119 128
55. E.J. Nestler Molecular mechanisms of drug addiction Neuropharmacology 47 2004 24 32
56. E.J. Nestler Is there a common molecular pathway for addiction? Nat. Neurosci. 8 2005 1445 1449
57. T. Onaka Neural pathways controlling central and peripheral oxytocin release during stress J. Neuroendocrinol. 16 2004 308 312
58. D. Parolaro, and T. Rubino Cannabis and drugs of abuse R. Mechoulam Cannabinoids as Therapeutics 2005 Birkhaeuser Verlag Basel 207 218
59. R.G. Pertwee Pharmacology of cannabinoid CB1 and CB2 receptors Pharmacol. Ther. 74 1997 129 180
60. M. Pistis, G. Porcu, M. Melis, M. Diana, and G.L. Gessa Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental stimulation Eur. J. Neurosci. 14 2001 96 102
61. L.G. Reijmers, J.M. van Ree, B.M. Spruijt, J.P. Burbach, and D. De Wied Vasopressin metabolites: a link between vasopressin and memory? Prog. Brain Res. 119 1998 523 535
62. D. Robbe, G. Alonso, and O.J. Manzoni Exogenous and endogenous cannabinoids control synaptic transmission in mice nucleus accumbens Ann. N. Y. Acad. Sci. 1003 2003 212 225
63. M.C. Sanudo-Pena, K. Tsou, E.R. Delay, A.G. Hohman, M. Force, and J.M. Walker Endogenous cannabinoids as an aversive or counter-rewarding system in the rat Neurosci. Lett. 223 1997 125 128
64. Z. Sarnyai, and G.L. Kovacs Role of oxytocin in the neuroadaptation to drugs of abuse Psychoneuroendocrinology 19 1994 85 117
65. Z. Sarnyai, M. Vecsernyes, F. Laczi, E. Biro, G. Szabo, and G.L. Kovacs Effects of cocaine on the contents of neurohypophyseal hormones in the plasma and in different brain structures in rats Neuropeptides 23 1992 27 31
66. H. Shojo, and Y. Kaneko Characterization and expression of oxytocin and the oxytocin receptor Mol. Genet. Metab. 71 2000 552 558
67. S.M. Silva, M.D. Madeira, C. Ruela, and M.M. Paula-Barbosa Prolonged alcohol intake leads to irreversible loss of vasopressin and oxytocin neurons in the paraventricular nucleus of the hypothalamus Brain Res. 925 2002 76 88
68. G. Tanda, and S.R. Goldberg Cannabinoids: reward, dependence, and underlying neurochemical mechanisms: a review of recent pre-clinical data Psychopharmacology 169 2003 115 134
69. 9-tetrahydrocannabinol in mice Psychopharmacology 147 2000 436 438
70. N.D. Volkow, J.S. Fowler, and G.-J. Wang The addicted human brain: insights from imaging studies J. Clin. Invest. 111 2003 1444 1451
71. K.L. Widnell, D.W. Self, S.B. Lane, D.S. Russell, V.A. Vaidya, M.J. Miserendino, C.S. Rubin, R.S. Duman, and E.J. Nestler Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens J. Pharmacol. Exp. Ther. 276 1996 306 315
72. R.G. Wilson Jr., S.K. Tahir, R. Mechoulam, S. Zimmerman, and A.M. Zimmerman Cannabinoid enantiomer action on the cytoarchitecture Cell Biol. Int. 20 1996 147 157
73. R.A. Wise Interactions between medial prefrontal cortex and meso-limbic components of brain reward circuitry Prog. Brain Res. 126 2000 255 262
74. R. Yoshimura, T. Kimura, D. Watanabe, and H. Kiyama Differential expression of oxytocin receptor mRNA in the developing rat brain Neurosci. Res. 24 1996 291 304
75. Z.D. You, J.H. Li, C.Y. Song, C.H. Wang, and C.L. Lu Chronic morphine treatment inhibits oxytocin synthesis in rats NeuroReport 11 2000 3113 3116
76. L.J. Young, and Z. Wang The neurobiology of pair bonding Nat. Neurosci. 7 2004 1048 1054
77. Z.D. You, J.H. Li, C.Y. Song, C.L. Lu, and C. He Oxytocin mediates the inhibitory action of acute lithium on the morphine dependence in rats Neurosci. Res. 41 2001 143 150
78. L.J. Young, M.M. Lim, B. Gingrich, T.R. Insel, S. Ando, A.S. Murthy, B.A. Eipper, I.M. Chaiken, Z. Wang, and K. Moody Cellular mechanisms of social attachment Horm. Behav. 40 2001 133 138
79. 9-THC on the expression of CB1 receptor mRNA in different rat brain regions Mol. Brain Res. 62 1998 141 149